Cryoport Inc (CYRX)

Currency in USD
14.62
+0.24(+1.67%)
Closed·
14.27-0.35(-2.39%)
·
CYRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.3014.67
52 wk Range
6.1616.73
Key Statistics
Prev. Close
14.38
Open
14.45
Day's Range
14.3-14.67
52 wk Range
6.16-16.73
Volume
502.11K
Average Volume (3m)
685.18K
1-Year Change
119.1904%
Book Value / Share
9.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.61
Upside
+6.78%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Cryoport Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.61
(+6.78% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy20.00+36.80%15.00MaintainJun 03, 2026
KeyBanc
Buy17.00+16.28%15.00MaintainMay 20, 2026
Guggenheim
Buy12.00-17.92%11.00MaintainMay 05, 2026
Needham
Buy15.00+2.60%13.00MaintainMay 05, 2026
BTIG
Buy17.00+16.28%15.00MaintainMay 05, 2026

Cryoport Inc SWOT Analysis


Cryoport's Crossroads
Explore Cryoport's strategic position in cold chain logistics, facing growth challenges amidst a declining stock price and market capitalization of $388 million
Financial Headwinds
Delve into Cryoport's revised revenue guidance and cost-cutting measures, aiming for adjusted EBITDA profitability by 2025 despite recent downward trends
Market Dynamics
Analyst targets range from $8 to $15 per share, reflecting mixed views on Cryoport's potential in the evolving cell and gene therapy secto
Future Trajectory
Learn how new FDA approvals and cost reduction initiatives could reshape Cryoport's growth prospects, balancing against ongoing challenges in key segments
Read full SWOT analysis

Cryoport Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue hit $47.8M (up 16% YoY), beating forecast of $44.87M; EPS of -$0.25 missed expectations by $0.03
  • Life Sciences Services segment drove growth with 18% increase; adjusted EBITDA improved $2.2M YoY to -$0.6M
  • Full-year 2026 revenue guidance raised to $192M-$196M range, reflecting confidence in business trajectory
  • Stock rose 0.48% to $10.40 in aftermarket trading despite EPS miss; company focuses on new products and facility expansion
  • CEO emphasized commitment to long-term growth through innovation; challenges include ongoing losses and macroeconomic uncertainties
Last Updated: 2026-05-04, 05:56 p/m
Read Full Transcript

Earnings

Latest Release
May 04, 2026
EPS / Forecast
-0.25 / -0.22
Revenue / Forecast
47.8M / 44.87M
EPS Revisions
Last 90 days

CYRX Income Statement

Compare CYRX to Peers and Sector

Metrics to compare
CYRX
Peers
Sector
Relationship
P/E Ratio
−16.5x−5.4x−0.5x
PEG Ratio
−0.100.040.00
Price/Book
1.6x2.5x2.6x
Price / LTM Sales
4.0x1.8x3.0x
Upside (Analyst Target)
2.6%20.1%58.6%
Fair Value Upside
Unlock24.0%10.2%Unlock

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company’s Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company’s products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
18.81M37.32%275.03M
Other Institutional Investors
35.02M62.68%511.93M
Public Companies & Retail Investors
0.000.00%0.00
Total
53.83M100.00%786.96M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Cadian Capital Management, LP9.48%4,776,34369,830
Morgan Stanley9.02%4,546,91366,476

People Also Watch

24.6400
FTK
+1.90%
40.72
PSIX
+0.34%
37.62
RAMP
0.00%
18.400
TH
+4.13%

FAQ

What Is the Cryoport Inc (CYRX) Stock Price Today?

The Cryoport Inc stock price today is 14.62 USD.

What Stock Exchange Does Cryoport Inc Trade On?

Cryoport Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Cryoport Inc?

The stock symbol for Cryoport Inc is "CYRX."

What Is the Cryoport Inc Market Cap?

As of today, Cryoport Inc market cap is 736.88M USD.

What Is Cryoport Inc's Earnings Per Share (TTM)?

The Cryoport Inc EPS (TTM) is -0.89.

When Is the Next Cryoport Inc Earnings Date?

Cryoport Inc will release its next earnings report on Aug 11, 2026.

From a Technical Analysis Perspective, Is CYRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cryoport Inc Stock Split?

Cryoport Inc has split 2 times.

How Many Employees Does Cryoport Inc Have?

Cryoport Inc has 688 employees.

What is the current trading status of Cryoport Inc (CYRX)?

As of Jun 15, 2026, Cryoport Inc (CYRX) is trading at a price of 14.62 USD, with a previous close of 14.38 USD. The stock has fluctuated within a day range of 14.30 USD to 14.67 USD, while its 52-week range spans from 6.16 USD to 16.73 USD.

What Is Cryoport Inc (CYRX) Price Target According to Analysts?

The average 12-month price target for Cryoport Inc is 15.61 USD, with a high estimate of 20 USD and a low estimate of 12 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +6.78% Upside potential.

What Is the CYRX Premarket Price?

CYRX's last pre-market stock price is 14.68 USD. The pre-market share volume is 160.00, and the stock has decreased by 0.30, or 2.09%.

What Is the CYRX After Hours Price?

CYRX's last after hours stock price is 14.27 USD, the stock has decreased by -0.35, or -2.39%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.